United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
United Therapeutics Corp (NASDAQ: UTHR) Delayed: 538.30 +1.71 (0.32%)
Previous Close $536.59    52 Week High $164.04 
Open $541.25    52 Week Low $97.52 
Day High $541.53    P/E 98.41 
Day Low $533.49    EPS $5.47 
Volume 620,875